Navigation Links
Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
Date:8/3/2011

SAN DIEGO, Aug. 3, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and six months ended June 30, 2011.

Cadence commercially launched OFIRMEV® (acetaminophen) injection, the first and only intravenous formulation of acetaminophen to be approved in the U.S., in January 2011. As of July 31, 2011, OFIRMEV had received formulary acceptance at over 1,150 hospitals, representing more than 50% of the targeted U.S. IV analgesic market opportunity for OFIRMEV. Cadence's launch execution has progressed from creating access to creating sales demand, as a result, sales of OFIRMEV have begun to accelerate. Second quarter net product revenue was $1.7 million, an increase of approximately 325% compared to the $0.4 million in net product revenue reported for the first quarter of the year.

During the second quarter, OFIRMEV was added to the formularies of a number of highly influential, community-based hospital networks and some of the most well-respected academic medical centers in the U.S. Additionally, the product was added to the U.S. Department of Defense's Joint Deployment Formulary, the core list of pharmaceutical products required for theater-level care of deployed military forces.

"I am pleased to report that as of June 30, over 1,200 institutions had placed an order for OFIRMEV. Additionally, at the end of the second quarter, nearly 60% of those accounts had placed multiple orders for OFIRMEV, representing a significant increase over the first quarter of this year, at which time only 36% of our customers had re-ordered the product," said Ted Schroeder, President and CEO of Cadence. "Thanks to strong demand by hospital physicians and tremendous exe
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
2. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
3. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
4. Cadence, Inc. Announces Major Expansion
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2011 Financial Results on May 5, 2011
6. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2011
7. Cadence, Inc. Expands Executive Team
8. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
9. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
10. Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011
11. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Report ... study showing you trends, R&D and predicted revenues ... kinase inhibitors? Now get the latest analysis for ... trends, results, opportunities and revenue forecasts. Visiongain,s ... using protein kinase inhibition and related technology. There ...
(Date:9/23/2014)... BURLINGTON, Mass. , Sept. 23, 2014 ... in pricing and reimbursement (P&R) decision criteria ... along with expert insights into each country, ... messaging across different markets.  Global market access ... very specific market access requirements and challenges—and ...
(Date:9/23/2014)... 2014 Research and Markets  has announced the ... report to their offering. Diabetes is a ... Over 382 million people are estimated to be currently suffering ... 592 million by 2035. With a very high prevalence, ... and India , an increasing proportion ...
Breaking Medicine Technology:Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 2Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 4Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 5Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Va., July 8, 2011 The Amerigroup Foundation recently ... the Rx Partnership to benefit the Rockbridge Area Free ... organization that works to provide uninsured Virginians with access ... broker to access and distribute free bulk prescription medications ...
... /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" ... of premium branded Traditional Chinese Medicine ("TCM") consumer ... attending and presenting at the upcoming 2011 Global ... at the Intercontinental Hotel (888 Howard Street) in ...
Cached Medicine Technology:Amerigroup Foundation Presents Grant to Rx Partnership 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 3
(Date:9/23/2014)... single day event in Japan will be held ... Tokyo. Clinical data scientists will meet and discuss various topics ... single day event in China will be held November ... scientists attending this event will discuss topics around CDISC ADaM ... collected in clinical studies and beyond. , India will ...
(Date:9/23/2014)... ZEPHYRHILLS, FL (PRWEB) September 23, 2014 ... opening of the newly renovated Women’s Health Center ... square feet of space, the specially designed center ... women in East Pasco County. The Women’s Health ... and pelvic floor health, labor and delivery through ...
(Date:9/23/2014)... of California, Davis, and Academia Sinica, the preeminent ... have entered into a collaborative agreement to develop ... couples cutting-edge research with opportunities to translate innovative ... , The agreement was signed Sept.12 in Taipei ... UC Davis and President Chi-Huey Wong of Academia ...
(Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
(Date:9/23/2014)... -- A test used to diagnose lung cancer may not ... are more common, a new analysis says. One ... of what,s known as functional imaging. For lung cancer, a ... to the study authors. Cancerous tumors generally look different ... lungs that don,t have cancer, according to background information in ...
Breaking Medicine News(10 mins):Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2
... his team has performed an Endoscopic surgery for Frontal Sinus ... 25 years old patient in Venkateswara Hospital in Chennai, Tamilnadu, ... inflammation of the meninges that covers the brain and spinal ... fluid is produced in the inner ventricles of the brain ...
... the approval of the Government is attracting brickbats and bouquets. ... the scheme which the ICICI-Lombard is // meant ... some experts who contend that it will do no good ... system in the state. ,Every year all ...
... A unique world class healthcare facility, supported by Welcare World ... region. // A full service ambulatory health care service comprising ... services had been recently inagurated in Knowledge Village. ... open from 8 am to 11 pm and fucntions 6 ...
... has announced that five new Vietnamese provinces are infected by ... spread of bird flu virus as already more than 21 ... flu virus. Though, Vietnamese scientists have revealed that they have ... help to understand the mechanism of virus transmission and the ...
... high fat diet has been found to suppress the ... that regulates insulin secretion (beta cells of the pancreas). ... ,This molecular mechanism between diabetes (Type ... the University of California. During early stages of the ...
... the Yale School of Medicine has revealed that diet ... Until recently it was believed that there was a ... carbonated soft drinks. In their study published in the ... the researchers report that the link is unfounded, and ...
Cached Medicine News:Health News:Health Insurance Scheme Generates Conflicting Opinions 2Health News:State Of The Art Healthcare Facility Opened In 'New Dubai' by Welcare 2Health News:Soft Drinks May Reduce Esophageal Cancer Risk 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: